Catheterization and Cardiovascular Interventions
Volume 92, Issue 4 pp. 678-679
Coronary Artery Disease

Bioresorbable vascular scaffold for the treatment of coronary in-stent restenosis: New dawn or frost on snow?

Junbo Ge MD, 

Corresponding Author

Junbo Ge MD

Department of Cardiology, Zhongshan Hospital Fudan University, Xuhui District, Shanghai City, China

Correspondence

Junbo Ge, MD, Department of Cardiology, Zhongshan Hospital Fudan University, Xuhui District, Shanghai City, China.

Email: [email protected]

Search for more papers by this author
First published: 19 October 2018
https://doi.org/10.1002/ccd.27880
Citations: 4
Funding information Ministry of Science and Technology of the People's Republic of China, Grant/Award Number: 2016YFC1102303; National Natural Science Fund of China, Grant/Award Number: 81521001

Key Points

  • BVS might be non-inferiority compared to DES or DEB in ISR treatment in terms of 1-year DOCE.
  • BVS, especially thinner-strut stent may be an attractive alternative in ISR setting.
  • Large prospective randomized trials are needed to provide convince evidences to direct clinical practice in the future.

CONFLICT OF INTEREST

Nothing to report.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.